Abstract:Introduction. Multiple myeloma is the second most common malignant hemopathy.
The average incidence of this disease in our country is 4.2-6.7/100,000
inhabitants per year. Despite significant progress in the overall survival
over the past 20 years, only 10-15% of patients achieve long-term remission
and an average survival that corresponds to the average life expectancy of
the general human population. The current recommendations for the treatment
of multiple myeloma are globally based on the… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.